← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Biomedisyn Corporation
Woodbridge, CT
$1,235,079
Total funding
2
Grants
Funding over time
peak $492.2K · FY2008–11$500K$375K$250K$125K$0
'08
'09
'10
'11
Funding mix
By agency
NIH$1,235,079 · 2
By mechanism
R41$1,235,079 · 2
Investigators at Biomedisyn Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Neuroprotective and Antiviral Effects of BMD-101 and BMD-104 in HIV Infection$251,163
R41 · FY2010 · MH
Neuroprotective and Antiviral Effects of BMD-101 and BMD-104 in HIV Infection$246,905
R41 · FY2011 · MH
Huperzine for Cognitive and Functional Impairment in Schizophrenia$246,022
R41 · FY2009 · MH
Huperzine for Cognitive and Functional Impairment in Schizophrenia$240,989
R41 · FY2010 · MH
Huperzine for Cognitive and Functional Impairment in Schizophrenia$215,851
R41 · FY2008 · MH
Huperzine for Cognitive and Functional Impairment in Schizophrenia$34,149
R41 · FY2009 · MH